Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:110 (9 July), doi:10.1136/bmj.331.7508.110-b
| The first 150 words of the full text of this article appear below. |
EDITORWe agree with Lemon and Dunnett that better methods of surveying the literature on animal experiments are needed,1 but we do not share their confidence in the utility of non-systematic reviews.
In clinical trials, systematic review and meta-analysis have made important contributions to our understanding of sources of bias, and the quality of clinical trials has improved as a result. We believe that the same approach can be used to increase our understanding of sources of bias in animal experiments, again leading to improvements in study quality.
Not to publish negative results from clinical trials is widely accepted as unethical, because this may lead to the study being unwittingly repeated by other investigators, exposing trial participants to risk of drug side effects with no prospect of benefit. We consider that non-publication of data from animal studies is equally unethical.
It is argued that tight control of experimental conditions
Malcolm R Macleod, specialist registrar, neurology
Western General Hospital, Edinburgh EH4 2XU malcolm@apoptosis.freeserve.co.uk
Shah Ebrahim, professor of epidemiology of ageing
Department of Social Medicine, University of Bristol, Bristol BS8 2PR
Ian Roberts, professor
Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT